Table 2 The detailed types and statistical significance between different congenital heart diseases in the study population (Group A versus Group B, acyanotic versus cyanotic subtypes)
Echo Findings | Group A (=45 children) No. (%) | Group B (=30 children) No. (%) | Test of significance | p value |
|---|---|---|---|---|
Congenital acyanotic heart diseases | ||||
ASD | 6 (13.3 %) | 4 (13.3 %) | χ2(0.000) | 1.0000 |
VSD | 14 (31.1 %) | 10 (33.4 %) | χ2(0.04085) | 0.8398 |
PDA | 7 (15.6 %) | 5 (16.7 %) | χ2(0.01653) | 0.8977 |
ASD+VSD | 4 (8.9 %) | 4 (13.3 %) | χ2(0.05247) | 0.8188 |
PS | 8 (17.8 %) | 5 (16.7 %) | χ2(0.01551) | 0.9009 |
Congenital MR | 1 (2.2 %) | 0 (0 %) | χ2(0.6757) | 0.4111 |
Galectin-3 (ng/dl) in acyanotic heart diseases | ||||
Mean ± SD | 20.1±4.9 | 5.8±4.9 | T (12.382) | < 0.0001* |
Congenital cyanotic heart diseases | ||||
TGA | 2 (4.4 %) | 1 (3.3 %) | χ2(0.05787) | 0.8099 |
TOF | 3 (6.7 %) | 1 (3.3 %) | χ2(0.01100) | 0.9165 |
Galectin-3 (ng/dl) in cyanotic heart diseases | ||||
Mean ± SD | 19.9±5.1 | 6.2±4.3 | T (12.114) | < 0.0001* |
p value | P1= 0.8500 | P2= 0.7380 | - | - |